All Stories

  1. Le virus de l’hépatite E
  2. New insights into HCV transmission
  3. Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein
  4. CD81 and Hepatitis C Virus (HCV) Infection
  5. The antimalarial ferroquine is an inhibitor of hepatitis C virus
  6. EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry
  7. The Role of CD81 in HCV and Plasmodium Infection
  8. Structural Basis of Ligand Interactions of the Large Extracellular Domain of Tetraspanin CD81
  9. Hepatocyte-derived cultured cells with unusual cytoplasmic keratin-rich spheroid bodies
  10. Interacting Regions of CD81 and Two of Its Partners, EWI-2 and EWI-2wint, and Their Effect on Hepatitis C Virus Infection
  11. Hepatitis C virus entry into the hepatocyte
  12. HCV Research 20 Years After Discovery: A Summary of the 16th International Symposium on Hepatitis C Virus and Related Viruses
  13. The Ig Domain Protein CD9P-1 Down-regulates CD81 Ability to Support Plasmodium yoelii Infection
  14. Occludine, une clé de plus pour l’entrée du virus de l’hépatite C
  15. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry
  16. The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry
  17. Early steps of the hepatitis C virus life cycle
  18. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry
  19. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins
  20. Hepatitis C virus entry: potential receptors and their biological functions
  21. Kinetics of HCV envelope proteins’ interaction with CD81 large extracellular loop
  22. Regulation of Hepatitis C Virus Polyprotein Processing by Signal Peptidase Involves Structural Determinants at the p7 Sequence Junctions
  23. Characterization of Functional Hepatitis C Virus Envelope Glycoproteins
  24. CD81-Dependent Binding of Hepatitis C Virus E1E2 Heterodimers
  25. Recognition of Native Hepatitis C Virus E1E2 Heterodimers by a Human Monoclonal Antibody
  26. Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins
  27. Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus
  28. Glycosylation of the hepatitis C virus envelope protein E1 occurs posttranslationally in a mannosylphosphoryldolichol-deficient CHO mutant cell line
  29. Glycosylation of the Hepatitis C Virus Envelope Protein E1 Is Dependent on the Presence of a Downstream Sequence on the Viral Polyprotein
  30. The Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins E1 and E2 Play a Major Role in Heterodimerization
  31. Charged Residues in the Transmembrane Domains of Hepatitis C Virus Glycoproteins Play a Major Role in the Processing, Subcellular Localization, and Assembly of These Envelope Proteins
  32. Hepatitis C Virus Glycoprotein Complex Localization in the Endoplasmic Reticulum Involves a Determinant for Retention and Not Retrieval
  33. Endoplasmic reticulum retention of hepatitis C virus glycoprotein complex E1E2: A role for the transmembrane domain of E2